Business
Press Release May 18 2026
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 18, 2026, titled "Strides Delivers Strong Performance with FY26 EBITDA at ₹9,253m, Operational PAT at ₹5,181m, 50% YoY Growth".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 18, 2026, titled "Strides Delivers Strong Performance with FY26 EBITDA at ₹9,253m, Operational PAT at ₹5,181m, 50% YoY Growth". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd